Grifols SA’s board recommended that shareholders reject Brookfield Asset Management’s indicative offer, which values the ...

Brookfield Asset Management is considering a €6.45 billion ($6.9 billion) bid for Grifols SA, with the drug maker’s board set ...

Packaging solutions company Amcor (AMCR) has agreed to acquire peer Berry Global Group (BERY) in an $8.4B all-stock ...

With Spanish plasma specialist Grifols turning down a potential multi-billion-dollar takeover bid, it’s likely back to the ...

Grifols SA’s board of directors said it won’t recommend that shareholders accept Brookfield Asset Management’s indicative ...

Nov 18 (Reuters) - Canadian fund Brookfield (BN.TO), opens new tab plans to offer about 7 billion euros ($7.4 billion) for ...

Grifols is anticipating a period of strong growth on the back of its recently FDA-approved intravenous immunoglobulin product ...

Grifols (GRFS) stock falls as Brookfield Asset Management (BAM) considers a $6.9B offer, which has met with opposition from ...

Grifols (GRFS) stock gains as banks aim to finalize an €11B debt package for Brookfield's (BAM) plan to take the healthcare ...

Banks are getting ready to submit final offers to Brookfield Asset Management for a debt package of about €11 billion ($11.6 ...

Grifols said on Tuesday that Canadian investment fund Brookfield’s BN-T potential €6.45-billion ($6.8-billion) offer ...

(Bloomberg) -- Grifols SA’s board recommended that shareholders reject Brookfield Asset Management’s indicative offer, which values the Spanish drugmaker at €6.45 billion ($6.8 billion).